Gastric Motility Disorder Drugs Market to Reach US$ 102.7 Bn by 2034 Amid Rising Digestive Health Concerns
The global gastric motility disorder drugs market is witnessing steady growth due to the rising burden of gastrointestinal disorders and the increasing aging population worldwide. According to recent industry analysis, the market was valued at US$ 57.6 Bn in 2023 and is projected to reach US$ 102.7 Bn by the end of 2034, expanding at a CAGR of 5.4% from 2024 to 2034. The market is gaining...
0 Commenti 0 condivisioni 47 Views 0 Anteprima
Sponsorizzato